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Abstract
Recent characterizations of methyl transferases as regulators of cellular processes have spurred
investigations into how methylation events might influence the HIV-1 life cycle. Emerging evidence
suggests that protein-methylation can positively and negatively regulate HIV-1 replication. How
DNA- and RNA- methylation might impact HIV-1 is also discussed.
Commentary
Biologically, methylation is executed by discrete enzymes
(methyltransferases) which recognize DNA, RNA and pro-
teins. Methylation of DNA, RNA or protein can regulate
gene expression, RNA metabolism, and protein activity.
Recently, protein methylation has stepped into the lime
light due to the identification and characterization of pro-
tein arginine methyltransferases (PRMTs) which catalyze
additions to arginine residues. PRMTs transfer one or two
methyl groups from S-adenosylmethinine (SAM) to the
guanidine-nitrogen atoms in arginine, forming methyl-
arginine and/or S-adenosylhomocysteine [1]. PRMTs are
ubiquitously expressed in cells; however, much is
unknown about their regulated expression and stability
[2].
Arginine methylation impacts cellular processes ranging
from transcription, RNA processing, and cell signaling.
PRMTs can function as transcriptional co-activators
through remodeling chromatin and modifying histone
tails. Methylation of histone H3 and H4 by CARM1 and
PRMT1 is thought to contribute to a histone code [3,4]
which programs gene expression. PRMTs also methylate
non-histone proteins, such as CBP, to modulate co-activa-
tor function [5,6]. RNA binding proteins (RBPs) such as
hnRNPs, Sam68, and Sm complex also have arginine-gly-
cine repeats, a motif recognized and methylated by
PRMTs. Methylation of RBPs may dictate activity as evi-
denced by findings that Sam68 and snRNPs require
methyl addition to localize properly in the nucleus and
assemble into appropriate multi-molecular complexes
[7,8].
Emerging evidence implicates methylation in regulated
HIV-1 replication [9-12]. Now two new reports in Retrovi-
rology [13,14] add to our understanding of how methyla-
tion could influence HIV-1 biology. In the first,
Willemsen et al. used HIV-1 infected CEM T-cells and pro-
virus transfected HEK293T cells to link protein methyla-
tion to virion infectivity. They employed adenosine
periodate (AdOx), a general inhibitor of many methyl-
transferases, to address the effect of methylation on HIV-
1 in tissue culture. Willemsen et al. found that AdOx treat-
ment increased virus production from both adherent cells
transfected with a proviral molecular clone and T-cells
infected with HIV-1. Interestingly, the authors saw
decreased p24 levels in infected CEM T-cells treated with
AdOx, which was accompanied by substantially increased
p24 amounts in the culture supernatants. This provocative
observation suggests that methylation may regulate the
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processing and/or assembly of HIV-1 Gag protein. This
interpretation makes sense because they also saw differ-
ences in the composition and size of virions produced in
the presence or absence of AdOx, a finding consistent with
perturbed virion assembly when methylation events are
inhibited. Finally, AdOx treatment was found to signifi-
cantly decrease HIV-1 infectivity; however, this decreased
infectivity was overcome when HIV-1 virions were pseu-
dotyped with VSV-G protein. The latter result invokes a
methylation step in either HIV-1 envelope-receptor bind-
ing and/or virus envelope-uncoating in newly infected
cells (Fig. 1).
In the second article, Invernizzi et al. described the novel
methylation in HIV-1 Rev's arginine-rich motif by PRMT6.
Here, they reported that PRMT6 binds Rev and decreases
the stability of Rev in cells (Fig. 1). Additionally, methyl-
ated Rev bound the RRE (Rev responsive element in HIV-
1 RNAs [15]) poorly and was associated with an attenu-
ated Rev-RRE-dependent export of viral transcripts from
the nucleus to cytoplasm. Thus, methylation in this con-
text of HIV-1 infection provides a negative influence.
Collectively, the two new articles extend the emerging
notion for methylation regulating HIV-1 biology. While
the activity described by Invernizzi et al. stems clearly
from PRMT6 methylation of Rev, the results accrued by
Willemsen et al. paint a less clear mechanistic picture. Wil-
lemsen  et al. used a broadly non-specific inhibitor of
methylation, AdOx. AdOx is a competitive inhibitor of all
SAM dependent methylation which includes protein-,
RNA-, and DNA- modifications. Hence, the findings from
Willemsen et al. while suggestive of an effect involving
HIV-1 envelope cannot formally exclude contributions
Schematic representation of steps at which methyltransferases may influence HIV-1 replication Figure 1
Schematic representation of steps at which methyltransferases may influence HIV-1 replication. Methyltransferases (italics) and 
their targeted steps in the HIV-1 life cycle are indicated.
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from Adox's action on unidentified RNA- or DNA- meth-
ylation.
So where do these reports lead us? The HIV-1 genome
contains 9 open reading frames which can encode 15 pro-
teins, and virus replication involves a complex interplay
between viral and cellular proteins. What remains to be
deciphered is the relative contribution of methylation on
virus-factors versus cellular macromolecules. In this
regard, Kwak et al. [12] have reported earlier that inhibi-
tion of arginine-methylation can also influence HIV-1
transcription. They showed that cellular transcription
elongation protein SPT5 is a substrate of protein arginine
methyltransferases PRMT1 and PRMT5, and that methyl-
ated SPT5 is less able to associate with RNA polymerase II
and to assist Tat in efficient elongation of HIV-1 LTR-
directed transcription.
Besides protein-methylation, there is compelling evidence
that DNA-methylation influences HIV-1 replication. CpG
methylation of LTR DNA has been reported to promote
viral latency [16-19]. Some of these effects are explained
by DNA-methylation impeding the binding of Sp1 and
NF-κB transcription factors to the LTR promoter [20,21].
Indeed, activation of viral expression from latently
infected cells does appear to correlate with loss of methyl-
ation of the HIV-1 LTR DNA.
Finally, what about RNA-methylation? RNA methyl mod-
ifications are involved in functional maturation of many
species of cellular RNAs including mRNA, rRNA, tRNA,
snRNA and snoRNA. Methylation of the RNA cap (7-
methylguanosine cap) is a critical processing step for cel-
lular and viral mRNAs. This action increases mRNA stabil-
ity and promotes efficient export and translation. Other
cap methyl modifications (e.g., hypermethylation – 2,2,7-
trimethylguanosine modification of mRNA caps) have
been identified in Oncorna viruses, Reo viruses, Sindbis
virus, and Caenorhabditis elegans mRNAs [22-25]. The sig-
nificance of these modifications remains undetermined.
We have also recently identified a cellular RNA methyl-
transferase whose activity appears to upregulate HIV-1
gene expression (unpublished). Going forward, a better
understanding of the varying complexities of methylation
and their myriad effects on virus replication may unveil
these processes as useful novel drug targets for HIV-1.
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